With thousands infected with the Ebola virus, millions of dollars are being pledged to develop treatment options. Three avenues that have potential but are a...
UCT biopharming group cements new international collaboration
The Biopharming Research Unit (BRU) at the University of Cape Town (UCT) has announced that it is joining forces with Canada-based biopharmaceutical company Medicago Inc. to develop a vaccine against Human papillomaviruses (HPV).
What makes this particular collaboration remarkable is that the vaccine in question will be produced in plants.
“We are excited and honoured to work with one of the world's most advanced companies in the field of plant-made vaccines,” said Prof. Ed Rybicki, Director of the BRU, in reference to Medicago’s earlier success in producing candidate vaccines against influenza viruses.
The BRU has itself been at the forefront of HPV vaccine and plant-produced therapeutic research for the last 10 years.
Dr Inga Hitzeroth, Deputy Director of the BRU, echoed Rybicki’s sentiment, adding that she looks forward to a profitable collaboration with Medicago. The Canadian organisation is providing the funding and some materials for the research, while the BRU provides the expertise to develop and produce the virus-like particles (VLPs) that will be used as vaccines against HPV.
“This collaboration has the potential to bring forth novel vaccine solutions against human papillomaviruses that provide improved protection from the wide variety of circulating virus strains,” said Marc-André D'Aoust, Vice-President of Research and Innovation at Medicago.
The Norwegian woman, infected by the Ebola in Sierra Leone and currently receiving treatment in Oslo, will get the last dose of the virus treatment medicine ZMapp
Federal officials are planning to sharply increase production of ZMapp, which is viewed by many experts as the most promising experimental drug for treating people infected with Ebola in West Africa.
The Department of Health and Human Services is in advanced discussions to enlist Caliber Biotherapeutics, a Texas company that can produce the drug in millions of tobacco plants, according to federal officials and pharmaceutical industry executives.
Ed Rybicki's insight:
"While production in tobacco is said to be faster and cheaper to get started, there is only limited tobacco capacity, while there is a huge capacity in the biotechnology industry to produce antibodies in CHO cells."
Really?? What has happened to Fraunhofer in Aachen, Icon Genetics, Fraunhofer USA, Medicago? Don't THEY have capacity?
The ability of plants to sense their nitrogen (N) microenvironment in the soil and deploy strategic root growth in N-rich patches requires exquisite systems integration. Remarkably, this new paradigm for systems biology research has intrigued plant biologists for more than a century, when a split-root framework was first used to study how plants sense and respond to heterogeneous soil nutrient environments. This systemic N-signalling mechanism, allowing plants to sense and forage for mineral nutrients in resource-rich patches, has important implications for agriculture. In this review, we will focus on how advances in the post-genomic era have uncovered the gene regulatory networks underlying systemic N-signalling. After defining how local and systemic N-signalling can be experimentally distinguished for molecular study using a split-root system, the genetic factors that have been shown to mediate local and/or systemic N-signalling are reviewed. Second, the genetic mechanism of this regulatory system is broadened to the whole genome level. To do this, publicly available N-related transcriptomic datasets are compared with genes that have previously been identified as local and systemic N responders in a split-root transcriptome dataset. Specifically, (i) it was found that transcriptional reprogramming triggered by homogeneous N-treatments is composed of both local and systemic responses, (ii) the spatio-temporal signature of local versus systemic responsive genes is defined, and (iii) the conservation of systemic N-signalling between Arabidopsis and Medicago is assessed. Finally, the potential mediators, i.e. metabolites and phytohormones, of the N-related long-distance signals, are discussed.
Open Faculty Positions in the Owensboro Cancer Research Program
The University of Louisville invites applications for two tenure track faculty positions in the Owensboro Cancer Research Program (OCRP), a Unit of the James Graham Brown Cancer Center, University of Louisville School of Medicine.
OCRP currently has three plant-made pharmaceutical products being evaluated in preclinical programs, with first-in-human clinical trials planned within the next three years. Several additional vaccine and therapeutics candidates are in our preclinical pipeline.
In 2014, our plant-made pharmaceuticals research programs secured in excess of $20 million in research funding from NIH, the Department of Defense and private philanthropy over the next five years. The program’s goal is fill the gaps between academic research, biopharmaceutical development and commercial-scale production to effectively bring plant-made pharmaceuticals from bench to bedside. OCRP seeks to employ professionals with a demonstrated commitment to the field of plant-based pharmaceuticals research. Candidates with interests in design of novel recombinant protein pharmaceuticals and diagnostics, design of plant expression hosts and process engineering for extraction of recombinant proteins from plants, are particularly encouraged to apply.
OCRP benefits from location in the same city as Kentucky Bioprocessing Inc., facilitating opportunities for collaborations on industrial-scale plant-made pharmaceutical projects. Faculty appointments in the School of Medicine offer unique opportunities to develop novel translational research programs developing biologic drugs expressed in plants. Faculty rank (assistant professor, associate professor, or professor) is contingent upon qualifications and experience. Candidates should hold a doctorate in a relevant discipline.
For appointment as full Professor, candidates must provide evidence of potential to transfer a vigorous and independently funded research program.
Associate Professor candidates should show substantial professional experience in industry or academia, and should preferably have currently funded research programs.
Assistant Professor candidates should show strong potential for developing an independent research program in plant-made pharmaceuticals.
Primary responsibilities will be in translational research and student research training. Exceptionally qualified faculty will be considered for appointment as University Scholar and/or appointment with immediate tenure. The search committee will accept applications until the positions are filled and will maintain candidate confidentially until on-campus interview.
Contact Dr. Kenneth E. Palmer, Executive Director of OCRP, for further information (Kenneth.palmer@louisville.edu).
Applicants should send an application letter to facultyrecruiting@ocrp.org outlining career research goals and interest in the position, curriculum vitae, and names/contact information of three individuals for letters of reference (MS Word or pdf).
Review of applications will begin November 15, 2014 and will continue until positions are filled.
(Phys.org) —A genetically engineered tobacco plant, developed with two genes from blue-green algae (cyanobacteria), holds promise for improving the yields of many food crops.
A transient expression system based on a deleted version of Cowpea mosaic virus (CPMV) RNA-2, termed CPMV-HT, in which the sequence to be expressed is positioned between a modified 5′ UTR and the 3′ UTR has been successfully used for the plant-based expression of a wide range of proteins, including heteromultimeric complexes. While previous work has demonstrated that alterations to the sequence of the 5′ UTR can dramatically influence expression levels, the role of the 3′ UTR in enhancing expression has not been determined. In this work, we have examined the effect of different mutations in the 3′UTR of CPMV RNA-2 on expression levels using the reporter protein GFP encoded by the expression vector, pEAQexpress-HT-GFP. The results showed that the presence of a 3′ UTR in the CPMV-HT system is important for achieving maximal expression levels. Removal of the entire 3′ UTR reduced expression to approximately 30% of that obtained in its presence. It was found that the Y-shaped secondary structure formed by nucleotides 125–165 of the 3′ UTR plays a key role in its function; mutations that disrupt this Y-shaped structure have an effect equivalent to the deletion of the entire 3′ UTR. Our results suggest that the Y-shaped secondary structure acts by enhancing mRNA accumulation rather than by having a direct effect on RNA translation. The work described in this paper shows that the 5′ and 3′ UTRs in CPMV-HT act orthogonally and that mutations introduced into them allow fine modulation of protein expression levels.
Progress with protein-based tuberculosis (TB) vaccines has been limited by poor availability of adjuvants suitable for human application. Here, we developed and tested a novel approach to molecular engineering of adjuvanticity that circumvents the need for exogenous adjuvants. Thus, we generated and expressed in transgenic tobacco plants the recombinant immune complexes (RICs) incorporating the early secreted Ag85B and the latency-associated Acr antigen of Mycobacterium tuberculosis, genetically fused as a single polypeptide to the heavy chain of a monoclonal antibody to Acr. The RICs were formed by virtue of the antibody binding to Acr from adjacent molecules, thus allowing self-polymerization of the complexes. TB-RICs were purified from the plant extracts and shown to be biologically active by demonstrating that they could bind to C1q component of the complement and also to the surface of antigen-presenting cells. Mice immunized with BCG and then boosted with two intranasal immunizations with TB-RICs developed antigen-specific serum IgG antibody responses with mean end-point titres of 1 : 8100 (Acr) and 1 : 24 300 (Ag85B) and their splenocytes responded to in vitro stimulation by producing interferon gamma. 25% of CD4+ proliferating cells simultaneously produced IFN-γ, IL-2 and TNF-α, a phenotype that has been linked with protective immune responses in TB. Importantly, mucosal boosting of BCG-immunized mice with TB-RICs led to a reduced M. tuberculosis infection in their lungs from log10 mean = 5.69 ± 0.1 to 5.04 ± 0.2, which was statistically significant. We therefore propose that the plant-expressed TB-RICs represent a novel molecular platform for developing self-adjuvanting mucosal vaccines.
RNA interference (RNAi) has emerged as a powerful genetic tool for scientific research over the past several years. It has been utilized not only in fundamental research for the assessment of gene function, but also in various fields of applied research, such as human and veterinary medicine and agriculture. In plants, RNAi strategies have the potential to allow manipulation of various aspects of food quality and nutritional content. In addition, the demonstration that agricultural pests, such as insects and nematodes, can be killed by exogenously supplied RNAi targeting their essential genes has raised the possibility that plant predation can be controlled by lethal RNAi signals generated in planta. Indeed, recent evidence argues that this strategy, called host-induced gene silencing (HIGS), is effective against sucking insects and nematodes; it also has been shown to compromise the growth and development of pathogenic fungi, as well as bacteria and viruses, on their plant hosts. Here, we review recent studies that reveal the enormous potential RNAi strategies hold not only for improving the nutritive value and safety of the food supply, but also for providing an environmentally friendly mechanism for plant protection.
Horizon meets the scientists and doctors seeking a cure for the Ebola virus.
Ed Rybicki's insight:
Great BBC programme, saw it last night - nice cameo appearance by Charles Arntzen! The programme was a little light on science when explaining how ZMapp is made, but pretty good otherwise.
Read About How a Texas Biotech Firm Affirms Readiness To Produce Commercial Quantities Of Anti-Ebola Vaccines And Biotherapeutics Quickly And Cost-Effectively If Asked.
Ed Rybicki's insight:
Apologies for only discovering this today, to Andreas Schiermeyer, who sent it to me!
The Norwegian woman, infected by the Ebola in Sierra Leone and currently receiving treatment in Oslo, will get the last dose of the virus treatment medicine ZMapp
Ed Rybicki's insight:
...and yet again, the emphasis is on how slow it is to make it - when the whole point of biofarming and transient expression is that it is supposed to be QUICK to make things, and easy to scale up production!!
What is the problem here?
...and Kenneth Palmer told me just today (Friday 10th Oct) what it is: "You may not be aware that the human dose of Zmapp is 12 grams per patient, 3 infusions of 4 grams each. Check the dose in recent Nature paper. If yield of one antibody is 100 mg per kg and you have to produce three antibodies for Zmapp... If you do the arithmetic you will see why the process is "slow"".
So.... Doing just that, you end up with 30 kg N benthamiana per gm of ZMapp as a best-case yield - meaning 360 kg PER PATIENT.
That's a LOT of N benth - and tooling up for that sort of plant production takes time. Thanks, Kenneth!
I would be VERY interested in a cost breakdown of ZMapp vs CHO cell-produced MAbs - because producing at that sort of scale MUST be prohibitively expensive in stainless steel?
Maize (Zea mays ssp. mays) is one of the most important crops worldwide and there are many reports in the literature on its constitutive and inducible defenses against pathogens and insects. However, research on its wild ancestors, the teosintes, with respect to resistance against these antagonists is limited. Here, we review what is known about the different arthropods and microbes that are associated with maize and teosintes in Mexico and Central America, the area of origin, and evaluate the plants' mechanisms of resistance against biotic stresses. Teosintes appear to have greater resistance against a number of pests than their cultivated counterpart. We therefore highlight the need to study the teosintes in order to identify resistance traits that can be improved in maize. As teosintes are at risk of becoming extinct, there is a need to protect their germplasm for future generations.
Ed Rybicki's insight:
All is well, except: "Figure 1: Insects and pathogens associated with maize (Zea mays ssp. mays) and teosintes (Zea spp.) in Mexico and Central America.
(g) the Maize streak virus..." !! NOT found in either place; limited to Africa and Indian Ocean island territories!
A new bioengineering experiment creates plants that can capture and sequester more carbon dioxide. This opens a new door in the realm of climate science.
SummaryVariation is essential to ecological and evolutionary dynamics, but genetic variation of quantitative traits may be concentrated in a limited number of dimensions, constraining ecoevolutionary dynamics. We describe high-dimension variation in natural accessions of the model alga, Chlamydomonas reinhardtii, and test the hypothesis that extensive fitness variation across 30 environments is constrained to a small number of axes.We used high-throughput phenotyping to investigate morphological, fitness, and genotype × environment (G × E) variation in 18 naturalC. reinhardtii accessions in 30 environments.The organismal phenotypes of cell cycle, cell size, and phototactic behavior exhibited substantial genetic variation between lines, and we found up to 74-fold fitness variation across accessions and environments. Approximately 47% of the extensive G × E variation is accounted for by the first two principal components (PCs) of the G-matrix corresponding to covariation in metals response, nitrogen availability, or salt and nutrient response.The natural variation of C. reinhardtii accessions supports the hypothesis that, despite abundant genetic variation across single environments, the species' adaptive response should be constrained along few major axes of selection. These results highlight the utility of natural accessions for integrating ecoevolutionary and genetic research.
Phytochrome photosensors control a vast gene network in streptophyte plants, acting as master regulators of diverse growth and developmental processes throughout the life cycle. In contrast with their absence in known chlorophyte algal genomes and most sequenced prasinophyte algal genomes, a phytochrome is found inMicromonas pusilla, a widely distributed marine picoprasinophyte (<2 µm cell diameter). Together with phytochromes identified from other prasinophyte lineages, we establish that prasinophyte and streptophyte phytochromes share core light-input and signaling-output domain architectures except for the loss of C-terminal response regulator receiver domains in the streptophyte phytochrome lineage. Phylogenetic reconstructions robustly support the presence of phytochrome in the common progenitor of green algae and land plants. These analyses reveal a monophyletic clade containing streptophyte, prasinophyte, cryptophyte, and glaucophyte phytochromes implying an origin in the eukaryotic ancestor of the Archaeplastida. Transcriptomic measurements reveal diurnal regulation of phytochrome and bilin chromophore biosynthetic genes in Micromonas. Expression of these genes precedes both light-mediated phytochrome redistribution from the cytoplasm to the nucleus and increased expression of photosynthesis-associated genes. Prasinophyte phytochromes perceive wavelengths of light transmitted farther through seawater than the red/far-red light sensed by land plant phytochromes. Prasinophyte phytochromes also retain light-regulated histidine kinase activity lost in the streptophyte phytochrome lineage. Our studies demonstrate that light-mediated nuclear translocation of phytochrome predates the emergence of land plants and likely represents a widespread signaling mechanism in unicellular algae.
Scientists have discovered a key molecular cog in a plant’s biological clock. In response to temperature, it controls the speed of circadian, or daily, rhythms.
Candida antarctica lipase B (CALB) is a versatile biocatalyst used for a wide range of biotransformation. Methods for low cost production of this enzyme are highly desirable. Here, we report a mass production method of CALB using transgenic rice seeds as the bioreactor. The transgenic rice transformed with the CALB gene under the control of the promoter of the rice seed storage protein GT1 was found to have accumulated a large quantity of CALB in seeds. The transgenic line with the highest lipolytic activity reached to 85 units per gram of dry seeds. One unit is defined as the amount of lipase necessary to liberate 1 μmol p-nitrophenol from p-nitrophenyl butyrate in 1 min. The rice recombinant lipase (rOsCALB) from this line represents 40% of the total soluble proteins in the crude seed extracts. The enzyme purified from the rice seeds had an optimal temperature of 40 °C, and optimal pH of 8.5, similar to that of the fermentation products. Test of its conversion ability as a biocatalyst for biodiesel production suggested that rOsCALB is functionally identical to the fermentation products in its industrial application.
The development and marketing of ‘novel’ genetically modified (GM) crops in which composition has been deliberately altered poses a challenge to the European Union (EU)'s risk assessment processes, which are based on the concept of substantial equivalence with a non-GM comparator. This article gives some examples of these novel GM crops and summarizes the conclusions of a report that was commissioned by the European Food Safety Authority on how the EU's risk assessment processes could be adapted to enable their safety to be assessed.
Sustained expression of transgenes in specified developmental patterns is commonly needed in plant biotechnology, but obstructed by transgene silencing. Here, we present a set of gene design rules, tested on the silencing-susceptible beetle luc and bacterial ims genes, expressed in sugarcane. Designs tested independently or in combination included removal of rare codons, removal of RNA instability sequences, blocking of likely endogenous sRNA binding sites and randomization of non-rare codons. Stable transgene expression analyses, on multiple independent lines per construct, showed greatest improvement from the removal of RNA instability sequences, accompanied by greatly reduced transcript degradation evident in northern blot analysis. We provide a set of motifs that readily can be eliminated concurrently with rare codons and undesired structural features such as repeat sequences, using Gene Designer 2.0 software. These design rules yielded 935- and 5-fold increased expression in transgenic callus, relative to the native luc and ims sequences; and gave sustained expression under the control of sugarcane and heterologous promoters over several years in greenhouse and field trials. The rules can be applied easily with codon usage tables from any plant species, providing a simple and effective means to achieve sustained expression of otherwise silencing-prone transgenes in plants.
To get content containing either thought or leadership enter:
To get content containing both thought and leadership enter:
To get content containing the expression thought leadership enter:
You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.
A great plug for both ZMapp and Icon!